Therefore, more research has focused on alternative strategies for overcoming TRAIL resistance in tumor cells, such as inducing the upregulation of DR4 or DR5, the downregulation of decoy receptors, or the inhibition of c-FLIP, XIAP, or Bcl-2 family members [9,10,11]. Here, TNFRSF10A is linked to neoplasm.